fluorodeoxyglucose f18 has been researched along with Koch's Disease in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (13.73) | 29.6817 |
2010's | 56 (54.90) | 24.3611 |
2020's | 32 (31.37) | 2.80 |
Authors | Studies |
---|---|
Lin, K; Miao, W; Yao, S; Zheng, J; Zheng, S | 1 |
Belmonte, G; Lavalle, M; Manfredi, R; Minordi, LM; Pallavicini, F | 1 |
Jiang, L; Li, Q | 1 |
Andronikou, S; Burger, C; Goussard, P; Rabie, H | 1 |
Chen, X; Huang, Z; Sun, R; Wei, J; Zeng, C | 1 |
Deng, Y; Wu, J; Xu, C; Zhang, W | 1 |
Benali, K; Berleur, M; Chapuis, E; Goulenok, T; Ottaviani, S; Papo, T; Sacre, K; Silbermann-Hoffman, O; van Gysel, D | 1 |
Alçın, G; Baloğlu, MC; Çermik, TF; Şahin, R; Tatar, G | 1 |
Guo, N; Li, H; Zhang, W; Zhao, M; Zhu, A | 1 |
Li, L; Li, Y; Xiao, L | 1 |
Bhasin, A; Hughes, ZH; Osborn, RL; Rustad, AM | 1 |
Abubakar, S; Ankrah, AO; Lawal, IO; Sathekge, MM | 1 |
Gao, G; Huang, L; Quan, B; Zhang, P; Zheng, W | 1 |
Mizuta, J; Ohnishi, H; Yamane, M; Yokoyama, A | 1 |
Wang, G; Wang, H; Wang, W; Yang, J; Yang, X | 1 |
Cui, Z; Feng, J; Huang, L; Li, J; Luo, Y; Ma, W; Tian, X; Xie, Y; Yuping, H; Zhang, K; Zhou, J | 1 |
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
Bahl, A; Kaur, M; Nahar, U; Sharma, A; Singh, H; Singhal, M | 1 |
Basu, S; Loharkar, S; Shah, H; Sonavane, SN | 1 |
Barios, M; Espinosa-Pereiro, J; Lorenzo-Bosquet, C; Molina, I; Molina-Morant, D; Salvador, F; Sánchez-Montalvá, A; Tórtola, T; Villar, A | 1 |
George, T; Joshi, PV; Joshi, S; Kulkarni, M; Sahasrabudhe, S; Shewalkar, B | 1 |
Budak, E; Yanarateş, A | 1 |
Chhabra, R; Kumar, R; Mittal, BR; Modi, M; Parihar, AS; Rana, N; Satapathy, S; Sood, A; Verma, R | 1 |
Bomanji, J; Priftakis, D; Riaz, S; Zumla, A | 1 |
Budiawan, H; Hutomo, F; Mulyanto, ID; Yudistiro, R | 1 |
Alavi, A; Bisson, G; Chandra Khangembam, B; Deogaonkar, V; Kumar, R; Seraj, SM; Vangu, MD | 1 |
Bhardwaj, H; Curley, M | 1 |
Dai, M; Han, J; Hu, Y; Zhang, J; Zhao, X | 1 |
Gu, B; He, X; Luo, Z; Song, S; Wang, J | 1 |
Igarashi, Y; Ishida, F; Kanai, S; Kawakami, T; Mitarai, S; Nakazawa, H; Natori, T; Nishina, S; Sakai, H; Ushiki, A; Yoshiyama, T | 1 |
Benali, K; Chauveheid, MP; Dossier, A; Ducrocq, G; Dulin, M; Goulenok, T; Papo, T; Para, M; Pasi, N; Pellenc, Q; Roriz, M; Sacre, K; van Gysel, D | 1 |
Benli, F; Güler, M; Ozmen, O; Tatci, E; Uslu Biner, I | 1 |
Ji, Z; Jiang, H; Ke, S; Li, A; Liao, S; Tian, M; Zhang, H | 1 |
Lambert, R; Martineau, P; Pelletier-Galarneau, M; Pham, X; Turpin, S; Zuckier, LS | 1 |
Hou, S; Shen, J; Tan, J | 1 |
Coleman, MT; Flynn, JL; Frye, LJ; Lin, PL; Maiello, P; Scanga, CA; Tomko, JA; White, AG | 1 |
Bakari, KH; Lan, X; Niyonkuru, A | 1 |
Gabriel, M; Huber, H; Kaiser, B; Lamprecht, B; Lang, D; Virgolini, I | 1 |
Barry, CE; Coussens, AK; Esmail, H; Graham, CM; Horswell, S; Lai, RP; Lesosky, M; O'Garra, A; Wilkinson, KA; Wilkinson, RJ | 1 |
Castaigne, C; de Wit, S; Garcia, C; Martin, C; Vierasu, I; Wyndham-Thomas, C | 1 |
Kumar, R; Mandavdhare, HS; Mittal, BR; Parihar, AS; Sharma, V; Vadi, SK | 1 |
Bharati, J; Gupta, KL; Kavanal, AJ; Kumar, R; Mittal, BR; Vadi, SK | 1 |
Chang, CW; Liu, RS; Shih, BF; Tsao, CH; Wang, HE; Wu, CY | 1 |
Jain, TK | 1 |
Eo, JS; Kim, WY; Lee, JB; Lee, S; Woo, SU | 1 |
Heysell, SK; Houpt, ER; Rehm, PK; Sifri, CD; Thomas, TA | 1 |
Andrade, BB; Cole, S; Hanna, D; Kim, P; Maeurer, M; Schito, M; Wallis, RS; Zumla, A | 1 |
Dong, A; Gong, J; Wang, Y; Zuo, C | 1 |
Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M | 1 |
Li, X; Liu, W; Wang, X; Yin, J | 1 |
Maes, A; Sathekge, M; Van de Wiele, C | 1 |
Dhull, VS; Karunanithi, S; Kumar, R; Mukherjee, A; Sharma, P | 1 |
Bomanji, J; Sathekge, MM; Vorster, M | 1 |
Han, SK; Jeong, YJ; Kim, YW; Lee, JS; Lee, SM; Nam, HY; Paeng, JC; Yim, JJ; Yoo, CG | 1 |
Coleman, MT; Fillmore, D; Frye, LJ; Janssen, C; Klein, E; Lin, PL; Maiello, P; Tomko, J | 1 |
Fujii, T; Hanada, S; Ishihara, M; Kishi, K; Kurosaki, A; Miyamoto, A; Morokawa, N; Takaya, H; Uruga, H | 1 |
Fujii, M; Itoigawa, Y; Iwakami, S; Takahashi, K | 1 |
Basu, S; Chhajed, PN; Shejul, Y | 1 |
Bagci, U; Bishai, WR; Foster, B; Jain, SK; Kubler, A; Larsson, C; Luna, B; Mollura, DJ | 1 |
DeMarco, VP; Foss, CA; Jain, SK; Klunk, M; Mease, RC; Ordonez, AA; Pokkali, S; Pomper, MG | 1 |
Abrunhosa, AJ; Appelberg, R; Barreira-Silva, P; Borges, M; Correia-Neves, M; Dinis-Oliveira, RJ; Ferreira, NC; Jordan, MB; Moreira, D; Resende, M; Silva, L; Silvestre, R | 1 |
Bomanji, J; Skoura, E; Zumla, A | 1 |
Barry, CE; Cai, Y; Chen, RY; Dartois, V; Dayao, E; Dodd, LE; England, K; Flynn, JL; Hammoud, D; Herscovitch, P; Richardson, M; Robbins, KK; Schimel, D; Via, LE; Weiner, DM; Zimmerman, MD | 1 |
Chen, G; Luo, DL; Wang, SX; Wang, SY | 1 |
Bonnefoy, M; Chidiac, C; Ferry, T; Gilbert, T | 1 |
Colletti, PM; Fellner, F; Gabriel, M; Giammarile, F; Hodolic, M; Huber, H; Lamprecht, B; Mandl, M; Rubello, D; Schinko, H; Skanjeti, A; Stelzmueller, I; Wunn, R | 1 |
Kang, F; Li, G; Li, X; Liu, C; Tian, F; Wang, J; Wang, S; Wang, Z; Yang, W; Zhang, M; Zhao, M | 1 |
Barry Iii, CE; Coussens, AK; Esmail, H; Flynn, JL; Graham, CM; Koegelenberg, CF; Lai, RP; Lesosky, M; O'Garra, A; Oni, T; Said-Hartley, Q; Walzl, G; Warwick, JM; Wilkinson, KA; Wilkinson, RJ; Young, DB | 1 |
Beneš, J; Bloomfield, M; Chroustová, D; Trnka, J | 1 |
Bassetti, M; Della Siega, P; Di Gregorio, F; Merelli, M; Righi, E; Scarparo, C; Screm, M | 1 |
Chen, CJ; Chiu, NT; Chou, CY; Lee, BF; Wu, PS; Yao, WJ | 1 |
Chung, JK; Kang, WJ; Kim, BS; Kim, S; Lee, DS; Lee, JW; Lee, MC | 1 |
Bishai, WR; Davis, SL; Jain, SK; Jedynak, B; Nuermberger, EL; Pomper, MG; Um, PK; Vidal, C | 1 |
Chen, LK; Chen, SW; Chen, YK; Yeh, CL | 1 |
Kgomo, M; Maes, A; Pottel, H; Sathekge, M; Stoltz, A; Van de Wiele, C | 1 |
Ito, K; Kubota, K; Morooka, M | 1 |
Kim, KS | 1 |
Chung, MJ; Jeong, HJ; Jeong, YJ; Kim, DW; Lee, CS; Lim, ST; Sohn, MH; Yim, CY | 1 |
Chen, B; Deng, QY; Guan, H; Tian, G; Xiao, Y | 1 |
Chen, B; Deng, Q; Guan, H; Tian, G; Xia, J; Xiao, Y | 1 |
Kgomo, M; Maes, A; Pottel, H; Sathekge, M; Stolz, A; Van De Wiele, C | 1 |
Buscombe, JR; Sathekge, M | 1 |
Kgomo, M; Maes, A; Sathekge, M; Stoltz, A; Van de Wiele, C | 1 |
Liu, Y | 1 |
Kosterink, JG | 1 |
Kim, BS; Kim, H; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
Kim, CG; Kim, DW | 1 |
Basu, S | 1 |
Abdul Rahim, N; Geso, M; Nordin, AJ; Razak, HR | 1 |
Cai, L; Chen, QS; Gao, S; Liu, GC | 1 |
Boué, F; Castilla-Lievre, MA; Desarnaud, S; Doucet-Populaire, F; Fior, R; Grenier, G; Guillet-Caruba, C; Martinez, V | 1 |
Li, D; Lü, PX | 1 |
Lee, MH; Oh, CG; Park, CH | 1 |
Higashi, T; Ishimori, T; Ishizu, K; Kitaichi, M; Li, M; Mamede, M; Manabe, T; Nakamoto, Y; Saga, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
Katsuragawa, Y; Kubota, K; Kuroki, H; Yago, Y; Yukihiro, M | 1 |
Cho, SH; Chung, N; Ha, JW; Ko, YG; Lee, JD; Rim, SJ; Yun, M | 1 |
Kang, K; Lim, I; Roh, JK | 1 |
Allard, M; Ducassou, D; Fernandez, P; Guyot, M; Lazaro, E; Viallard, JF | 1 |
Bai, RJ; Gao, S; Li, YJ; Zhang, Y | 1 |
Lin, KH; Peng, NJ; Wang, JH | 1 |
Balakrishnan, VB; Chawla, M; Das, CJ; Kumar, R; Malhotra, A | 1 |
Amartey, J; Bakheet, SM; Ezzat, A; Kandil, A; Powe, J; Rostom, A | 1 |
14 review(s) available for fluorodeoxyglucose f18 and Koch's Disease
Article | Year |
---|---|
Molecular Imaging of Tuberculosis.
Topics: Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Towards more accurate
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Latent Tuberculosis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis | 2020 |
Novel Quantitative PET Imaging Techniques in Tuberculosis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tuberculosis | 2020 |
Topics: Child; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thorax; Tuberculosis | 2017 |
Topics: Comorbidity; Fluorodeoxyglucose F18; Granulomatous Disease, Chronic; Humans; Lung; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Tuberculosis | 2018 |
Tuberculosis biomarkers discovery: developments, needs, and challenges.
Topics: Antigens, Bacterial; Antitubercular Agents; Biomarkers; Disease Progression; DNA, Bacterial; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Gene Expression Regulation, Bacterial; Humans; Interferon-gamma; Interleukin-18; Lipopolysaccharides; Metabolome; MicroRNAs; Multimodal Imaging; Mycobacterium tuberculosis; Polymerase Chain Reaction; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis Vaccines | 2013 |
Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis; Whole Body Imaging | 2013 |
FDG-PET imaging in HIV infection and tuberculosis.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; HIV Infections; Humans; Positron-Emission Tomography; Tuberculosis; Whole Body Imaging | 2013 |
Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.
Topics: Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2014 |
Imaging in tuberculosis.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary | 2015 |
Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Positron-Emission Tomography; Sarcoma, Kaposi; Tomography, X-Ray Computed; Tuberculosis | 2011 |
Positron emission tomography in the diagnosis and treatment management of tuberculosis.
Topics: Antitubercular Agents; Fluorodeoxyglucose F18; Humans; Mycobacterium tuberculosis; Positron-Emission Tomography; Tuberculoma; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2011 |
[Application of fluorine-18 fluorodeoxyglucose-positron emission tomography and positron emission tomography computed tomography in patients with tuberculosis].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2012 |
3 trial(s) available for fluorodeoxyglucose f18 and Koch's Disease
Article | Year |
---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Tuberculosis | 2016 |
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity.
Topics: Calcinosis; Carcinoma, Non-Small-Cell Lung; Contrast Media; Endemic Diseases; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Tomography, X-Ray Computed; Tuberculosis | 2009 |
86 other study(ies) available for fluorodeoxyglucose f18 and Koch's Disease
Article | Year |
---|---|
68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Peritoneum; Positron Emission Tomography Computed Tomography; Quinolines; Tuberculosis | 2022 |
Usefulness of
Topics: Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Tuberculosis | 2022 |
Diffuse Tracheobronchial Tuberculosis With Left Pulmonary Tuberculosis Displayed on 18F-FDG PET/CT.
Topics: Bronchi; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Tuberculosis; Tuberculosis, Pulmonary | 2022 |
Biopsy site identified with FDG PET-CT for diagnosis of tuberculosis in a child.
Topics: Biopsy; Child; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2022 |
68Ga-FAPI and 18F-FDG PET/CT Findings in a Patient With Pancreatic Tuberculosis Mimicking Malignant Tumor.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Tuberculosis; Young Adult | 2022 |
Primary Solitary Tuberculosis in the Hepatic Round Ligament Detected by 68Ga-FAPI PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Round Ligament of Liver; Tuberculosis | 2022 |
Musculoskeletal Tuberculosis: New Insights on Diagnosis Strategy and Treatment.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Musculoskeletal System; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2022 |
Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis on 68 Ga-FAPI-04 and 18 F-FDG PET/CT.
Topics: Adult; Ascites; Female; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Tuberculosis | 2022 |
Solitary Periaortic Tuberculous Granuloma Mimicking Neoplastic Disease on 18 F-FDG PET/CT.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Tuberculosis | 2022 |
Solitary Chest Wall Tuberculosis Mimicking a Malignancy Demonstrated on FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Wall; Tomography, X-Ray Computed; Tuberculosis | 2022 |
Non-pulmonary Disseminated Tuberculosis Complicated by Constrictive Pericarditis and Cutaneous Gumma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mycobacterium tuberculosis; Pericarditis, Constrictive; Stroke Volume; Tuberculosis; Ventricular Function, Left; Young Adult | 2022 |
Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non-Small Cell Lung Cancer from Tuberculosis.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Cell-Free Nucleic Acids; DNA, Neoplasm; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tuberculosis | 2023 |
Tracheobronchial Tuberculosis Mimicking Malignancy on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.
Topics: Bronchi; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Trachea; Tuberculosis | 2023 |
New Onset of Tuberculosis Complicating FDG PET/CT Evaluation in Patient With Recent Chimeric Antigen Receptor T-Cell Therapy.
Topics: Adolescent; Antigens, CD19; Cell- and Tissue-Based Therapy; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Positron Emission Tomography Computed Tomography; Receptors, Chimeric Antigen; Tuberculosis | 2023 |
Differential diagnosis of lung cancer and tuberculosis based on 18 F-fluorodeoxyglucose PET/CT multi-time points imaging.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2023 |
Multimodality imaging of myocardial tuberculosis presenting as right ventricular cardiomyopathy: A case report.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2023 |
What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of
Topics: Fluorodeoxyglucose F18; Heart; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2023 |
Usefulness of FDG PET/CT in the management of tuberculosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hospitalization; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tuberculosis; Young Adult | 2019 |
The Great Mimicker-Tuberculosis Involving Prostate and Vertebrae Posing as Metastatic Prostate Carcinoma on FDG PET/CT.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Spine; Tuberculosis | 2020 |
Disseminated Tuberculosis and Saccular Aneurysm Findings on FDG PET/CT in a Patient With Polyarteritis Nodosa.
Topics: Aneurysm; Fluorodeoxyglucose F18; Humans; Polyarteritis Nodosa; Positron Emission Tomography Computed Tomography; Tuberculosis | 2021 |
18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome; Tuberculosis | 2020 |
False positive finding from malignancy-like lesions on FDG PET/CT: case report of tuberculosis patients.
Topics: Antitubercular Agents; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Treatment Outcome; Tuberculosis | 2020 |
Disseminated Bacillus Calmette-Guérin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guérin Therapy.
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tuberculosis; Urinary Bladder Neoplasms | 2020 |
Value of
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tuberculosis | 2021 |
68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Tuberculosis | 2020 |
Isolated splenic Mycobacterium tuberculosis complex infection in an immunocompetent individual with FDG-PET positive mass.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Mycobacterium tuberculosis; Positron-Emission Tomography; Splenic Diseases; Tuberculosis; Young Adult | 2021 |
Management of patients with myocardial tuberculosis: A case series.
Topics: Adult; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tuberculosis | 2021 |
Presentation of genital tuberculosis detected on FDG PET/CT scan resembling a primary gynecologic tumor and metastases.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genitalia; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tuberculosis | 2021 |
Simultaneous adrenal tuberculosis and renal oncocytoma mimicking malignant masses incidentally detected by
Topics: Adenoma, Oxyphilic; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2022 |
Case report: multiple systemic disseminated tuberculosis mimicking lymphoma on 18F-FDG PET/CT.
Topics: Antitubercular Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Whole Body Imaging | 2017 |
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates.
Topics: Animals; Fluorodeoxyglucose F18; Macaca; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Primates; Radiopharmaceuticals; Tuberculosis | 2017 |
SUV as a Possible Predictor of Disease Extent and Therapy Duration in Complex Tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Time Factors; Tuberculosis; Young Adult | 2018 |
Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.
Topics: Antibodies; Antigen-Antibody Complex; Cluster Analysis; Coinfection; Comorbidity; Complement System Proteins; Disease Progression; Fluorodeoxyglucose F18; HIV Infections; Humans; Interferons; Oligonucleotide Array Sequence Analysis; Positron Emission Tomography Computed Tomography; Signal Transduction; Transcription, Genetic; Transcriptional Activation; Transcriptome; Tuberculosis | 2018 |
Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study.
Topics: Adult; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis | 2018 |
Demonstration of Tubercular "Abdominal Cocoon" (Sclerosing Encapsulating Peritonitis) in 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Peritonitis; Positron Emission Tomography Computed Tomography; Tuberculosis | 2018 |
18F-FDG PET/CT Demonstrates Renal Cell Cancer in a Transplant With Synchronous Intestinal Infection.
Topics: Biopsy; Carcinoma, Renal Cell; Endoscopy; Fluorodeoxyglucose F18; Humans; Intestines; Kidney Neoplasms; Kidney Transplantation; Male; Positron Emission Tomography Computed Tomography; Tuberculosis; Young Adult | 2019 |
Micro-PET imaging of [18F]fluoroacetate combined with [18F]FDG to differentiate chronic Mycobacterium tuberculosis infection from an acute bacterial infection in a mouse model: a preliminary study.
Topics: Acute Disease; Animals; Chronic Disease; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorodeoxyglucose F18; Glycolysis; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Positron-Emission Tomography; Tuberculosis | 2019 |
Tuberculosis Presenting as Cutaneous Erythema Nodosum on 18F-FDG PET/CT.
Topics: Erythema Nodosum; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin; Tuberculosis | 2019 |
Lymphadenopathy by tuberculosis seemed like metastasis on FDG PET/CT in patients with breast carcinoma.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphadenopathy; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Paget's Disease, Mammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Tuberculosis, Lymph Node | 2019 |
18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series.
Topics: Aged; Antitubercular Agents; Drug Resistance, Bacterial; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Tuberculosis | 2013 |
FDG PET/CT findings of common bile duct tuberculosis.
Topics: Common Bile Duct; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2014 |
[Diagnostic value of (18)F-FDG PET/CT in extrapulmonary tuberculosis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tuberculosis; Young Adult | 2013 |
Lymphoma and tuberculosis: temporal evolution of dual pathology on sequential 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2014 |
(18)F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Interferon-gamma Release Tests; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Tuberculin Test; Tuberculosis | 2014 |
Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques.
Topics: Animals; Disease Progression; Fluorodeoxyglucose F18; Macaca fascicularis; Monkey Diseases; Mycobacterium tuberculosis; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed; Tuberculosis | 2014 |
[Evaluation of mycobacterial infections using 18F-fluorodeoxyglucose-positron emission tomography: results of nine cases].
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary | 2014 |
Interesting radiological images of a tuberculous abscess.
Topics: Abscess; Aged; Fluorodeoxyglucose F18; Humans; Male; Mycobacterium tuberculosis; Thoracic Wall; Tomography, Emission-Computed; Tuberculosis | 2014 |
18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Female; Fever; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Splenic; Whole Body Imaging | 2014 |
In vivo prediction of tuberculosis-associated cavity formation in rabbits.
Topics: Animals; Dental Pulp Cavity; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tooth Diseases; Tuberculosis | 2015 |
Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice.
Topics: Acetamides; Animals; Antitubercular Agents; Cytokines; Diagnostic Imaging; Diarylquinolines; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Iodine Radioisotopes; Lung; Mice, Inbred C3H; Mycobacterium tuberculosis; Positron-Emission Tomography; Pyrazoles; Pyrimidines; Tomography, Emission-Computed, Single-Photon; Tuberculosis | 2015 |
The Warburg effect in mycobacterial granulomas is dependent on the recruitment and activation of macrophages by interferon-γ.
Topics: Animals; Fluorodeoxyglucose F18; Glycolysis; Granuloma; Interferon-gamma; Lactic Acid; Macrophage Activation; Macrophages; Mice; Mice, Knockout; Mycobacterium avium; Radiopharmaceuticals; Tuberculosis | 2015 |
A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets.
Topics: Animals; Antitubercular Agents; Callithrix; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorodeoxyglucose F18; Granuloma; Male; Mycobacterium tuberculosis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Tuberculosis | 2015 |
18F-FDG PET/CT Images in a Patient With Primary Chest Wall Tuberculosis Mimicking Malignant Tumor.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Wall; Tomography, X-Ray Computed; Tuberculosis | 2016 |
Tuberculosis of the cavum revealed by acute facial pain.
Topics: Acute Pain; Aged, 80 and over; Diagnosis, Differential; Facial Pain; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Nasopharyngeal Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2015 |
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With Tuberculosis.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2016 |
Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[
Topics: Adult; Coinfection; Disease Progression; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Interferon-gamma Release Tests; Latent Tuberculosis; Male; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Radiography, Thoracic; Radiopharmaceuticals; South Africa; Sputum; Tuberculosis; Tuberculosis, Pulmonary | 2016 |
The role of (18)F-FDG PET/CT in diagnosis and therapeutic approach in small child with MSMD.
Topics: Antitubercular Agents; BCG Vaccine; Child, Preschool; Diagnosis, Differential; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Patient Care Planning; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tuberculosis | 2016 |
Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis.
Topics: Bacterial Infections; Case-Control Studies; Diagnosis, Differential; Discitis; Female; Fluorodeoxyglucose F18; Humans; Intervertebral Disc; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tuberculosis | 2017 |
Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT.
Topics: Carbonic Anhydrases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.
Topics: Animals; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Granuloma; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tuberculosis | 2009 |
Abnormal FDG PET imaging in tuberculosis appearing like mesothelioma: anatomic delineation by CT can aid in differential diagnosis.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2009 |
Impact of FDG PET on the management of TBC treatment. A pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Infant; Joint Diseases; Lung; Lymph Nodes; Male; Middle Aged; Pilot Projects; Pleural Effusion; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2010 |
18F-FDG PET/CT findings of pharyngeal tuberculosis.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Oropharynx; Palatine Tonsil; Pharyngeal Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2010 |
Primary nasopharyngeal tuberculosis mimicking carcinoma: a potentially false-positive PET/CT finding.
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis | 2010 |
'Hot liver' on 18F-FDG PET/CT imaging in a patient with hepatosplenic tuberculosis.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed; Tuberculosis | 2010 |
Multi-site abdominal tuberculosis mimics malignancy on 18F-FDG PET/CT: report of three cases.
Topics: Abdominal Neoplasms; Adult; Antitubercular Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis | 2010 |
FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tuberculosis | 2010 |
FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging.
Topics: Adult; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tuberculosis | 2010 |
Can positron emission tomography work in the African tuberculosis epidemic?
Topics: Africa; Epidemics; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Tuberculosis | 2011 |
Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antitubercular Agents; CD4 Lymphocyte Count; Drug Resistance, Multiple, Bacterial; Female; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Spleen; Treatment Outcome; Tuberculosis | 2011 |
Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bone Marrow; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Lumbar Vertebrae; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spleen; Spondylitis; Suppuration; Tomography, X-Ray Computed; Tuberculosis; Young Adult | 2011 |
Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.
Topics: Aged; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2011 |
18F-FDG PET/CT as a sensitive and early treatment monitoring tool: will this become the major thrust for its clinical application in infectious and inflammatory disorders?
Topics: AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Tuberculosis | 2012 |
Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis; Tuberculosis, Pulmonary; Young Adult | 2011 |
[Characteristics of extrapulmonary tuberculosis in (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography: experience from 39 cases].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Tuberculosis; Young Adult | 2012 |
(18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Whole Body Imaging; Young Adult | 2012 |
F-18 FDG positron emission tomographic imaging in bilateral iliopsoas abscesses.
Topics: Adolescent; Antitubercular Agents; Citrates; Drainage; Fluorodeoxyglucose F18; Gallium; Humans; Male; Psoas Abscess; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Tuberculosis | 2002 |
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Topics: Adenocarcinoma; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Neoplasm Metastasis; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Time Factors; Tuberculosis | 2005 |
Cold tuberculous abscess identified by FDG PET.
Topics: Abscess; Aged; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Rectal Diseases; Tuberculosis; Tuberculosis, Spinal | 2005 |
Images in cardiovascular medicine. Assessment of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis with 18F-2-deoxyglucose positron emission tomography.
Topics: Aged; Antitubercular Agents; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Pericardial Effusion; Pericarditis, Constrictive; Positron-Emission Tomography; Treatment Outcome; Tuberculosis | 2006 |
Positron emission tomographic findings in a tuberculous brain abscess.
Topics: Abscess; Brain; Brain Abscess; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2007 |
Systemic tuberculosis presenting as an epiglottic mass detected on F-18 FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Epiglottis; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis | 2007 |
Systemic disseminated tuberculosis mimicking malignancy on F-18 FDG PET-CT.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Mycobacterium Infections; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT.
Topics: Adult; Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
F-18 FDG uptake in breast infection and inflammation.
Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematoma; Humans; Mastitis; Middle Aged; Postoperative Hemorrhage; Radiopharmaceuticals; Staphylococcal Infections; Tomography, Emission-Computed; Tuberculosis | 2000 |